These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
76 related articles for article (PubMed ID: 16832824)
1. Periodontitis destructions are restored by synthetic glycosaminoglycan mimetic. Lallam-Laroye C; Escartin Q; Zlowodzki AS; Barritault D; Caruelle JP; Baroukh B; Saffar JL; Colombier ML J Biomed Mater Res A; 2006 Dec; 79(3):675-83. PubMed ID: 16832824 [TBL] [Abstract][Full Text] [Related]
2. ReGeneraTing agents matrix therapy regenerates a functional root attachment in hamsters with periodontitis. Lallam-Laroye C; Baroukh B; Doucet P; Barritault D; Saffar JL; Colombier ML Tissue Eng Part A; 2011 Sep; 17(17-18):2359-67. PubMed ID: 21548712 [TBL] [Abstract][Full Text] [Related]
3. A new approach to treat tissue destruction in periodontitis with chemically modified dextran polymers. Escartin Q; Lallam-Laroye C; Baroukh B; Morvan FO; Caruelle JP; Godeau G; Barritault D; Saffar JL FASEB J; 2003 Apr; 17(6):644-51. PubMed ID: 12665477 [TBL] [Abstract][Full Text] [Related]
4. Increased expression of extracellular matrix metalloproteinase inducer is associated with matrix metalloproteinase-1 and -2 in gingival tissues from patients with periodontitis. Dong W; Xiang J; Li C; Cao Z; Huang Z J Periodontal Res; 2009 Feb; 44(1):125-32. PubMed ID: 19515022 [TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical localization of Toll-like receptors 1-10 in periodontitis. Beklen A; Hukkanen M; Richardson R; Konttinen YT Oral Microbiol Immunol; 2008 Oct; 23(5):425-31. PubMed ID: 18793367 [TBL] [Abstract][Full Text] [Related]
6. Histologic and clinical evaluation of an allogeneic bone matrix for the treatment of periodontal osseous defects. Mellonig JT Int J Periodontics Restorative Dent; 2006 Dec; 26(6):561-9. PubMed ID: 17243329 [TBL] [Abstract][Full Text] [Related]
13. [Cytological issues of Curiosin's influence on the inflammatory processes in parodontal tissues]. Nanobashvili KV; Okropiridze TV; Kapanadze RV Georgian Med News; 2006 Jun; (135):57-60. PubMed ID: 16905810 [TBL] [Abstract][Full Text] [Related]
14. Role of systemic and local administration of selective inhibitors of cyclo-oxygenase 1 and 2 in an experimental model of periodontal disease in rats. Queiroz-Junior CM; Pacheco CM; Maltos KL; Caliari MV; Duarte ID; Francischi JN J Periodontal Res; 2009 Apr; 44(2):153-60. PubMed ID: 19210344 [TBL] [Abstract][Full Text] [Related]
15. Experimental periodontitis in mice selected for maximal or minimal inflammatory reactions: increased inflammatory immune responsiveness drives increased alveolar bone loss without enhancing the control of periodontal infection. Trombone AP; Ferreira SB; Raimundo FM; de Moura KC; Avila-Campos MJ; Silva JS; Campanelli AP; De Franco M; Garlet GP J Periodontal Res; 2009 Aug; 44(4):443-51. PubMed ID: 18973535 [TBL] [Abstract][Full Text] [Related]
16. Human beta-defensin-1 and -2 and matrix metalloproteinase-25 and -26 expression in chronic and aggressive periodontitis and in peri-implantitis. Kuula H; Salo T; Pirilä E; Hagström J; Luomanen M; Gutierrez-Fernandez A; Romanos GE; Sorsa T Arch Oral Biol; 2008 Feb; 53(2):175-86. PubMed ID: 17996844 [TBL] [Abstract][Full Text] [Related]
17. Cannabidiol decreases bone resorption by inhibiting RANK/RANKL expression and pro-inflammatory cytokines during experimental periodontitis in rats. Napimoga MH; Benatti BB; Lima FO; Alves PM; Campos AC; Pena-Dos-Santos DR; Severino FP; Cunha FQ; Guimarães FS Int Immunopharmacol; 2009 Feb; 9(2):216-22. PubMed ID: 19070683 [TBL] [Abstract][Full Text] [Related]